What research says it may help with, and how it works in the body
Compounding of unknown risks: Combining two compounds with incomplete human safety data multiplies the uncertainty considerably
The reconstituted solution must be prepared according to the antibiotic's prescribing information, which specifies the exact volume of SWFI required and the appropriate route of administration
It distinguishes cystic from solid masses, evaluates vascularity, and guides needle aspiration or biopsy
A GP or specialist can assess underlying health conditions that may increase the risk of adverse effects and can advise on licensed, evidence-based alternatives available through NHS or private prescribing pathways
For research protocols using the 10mg or 12mg maintenance dose, the injection volume should be accounted for in the reconstitution plan